Search for "manufacture" in Full Text gives 52 result(s) in Beilstein Journal of Organic Chemistry.
Beilstein J. Org. Chem. 2017, 13, 251–256, doi:10.3762/bjoc.13.28
Graphical Abstract
Figure 1: Retrosynthetic pathway for the synthesis of the target carbocyclic nucleoside methylphosphonates.
Scheme 1: Reagents and conditions: (a) (CH3O)2P(O)CH3, n-BuLi, THF, −78 °C/rt, 2 h, 63%; (b) H2, Pd/C, MeOH, ...
Scheme 2: Reagents and conditions: (a) N6-bis-Boc-adenine or 2-amino-6-chloropurine, PPh3, DIAD, THF, 0 °C to...
Scheme 3: Reagents and conditions: (a) N6-bis-Boc-adenine, PPh3, DIAD, THF, rt, 56%; (b) TFA, Cl(CH2)2Cl, rt,...
Figure 2: Numbering for 14 and 16.
Figure 3: Selected NOESY correlations for compound (+/−)-16.
Scheme 4: Reagents and conditions: (a) i) Boc2O, DMAP, THF, rt; ii) K2CO3, MeOH, 75%; (b) PPh3, DIAD, THF, rt...
Scheme 5: Reagents and conditions: (a) N6-Bz-adenine or 2-amino-6-chloropurine, PPh3, DIAD, THF, 0 °C to rt, ...
Beilstein J. Org. Chem. 2017, 13, 120–126, doi:10.3762/bjoc.13.15
Graphical Abstract
Scheme 1: Diels–Alder reaction of myrcene (1), with various dienophiles 2.
Figure 1: Kinetic studies of the Diels–Alder reaction between myrcene (1) and acrylic acid (2b); a) for diffe...
Figure 2: Comparison of conversions in three different reactors for the Diels–Alder reaction of myrcene (1) w...
Beilstein J. Org. Chem. 2017, 13, 111–119, doi:10.3762/bjoc.13.14
Graphical Abstract
Scheme 1: The reaction of (R)-(−)-carvone (1) with semicarbazide to form the corresponding semicarbazone 2.
Figure 1: CAD model of SL reactor design RD1 (left), RD1 with attached sprung clip (centre), commercially ava...
Figure 2: Energy versus wavelength spectra comparing the amount of stray light being picked up by the detecto...
Figure 3: Reactor set-up for carvone optimisation using RD1 as an inline spectroscopic flow cell. Reagents we...
Figure 4: RD1 held in place within the DAD compartment of an Agilent 1100 HPLC.
Figure 5: Optimisation plot for the SIMPLEX optimisation of semicarbazone 2. Optimum reaction conditions with...
Figure 6: SLM reactor RD2 (left), CAD model of RD2 (right). External dimensions of RD2 are 100 (length) × 20 ...
Figure 7: RD2 held in place within the thermostatted Agilent 1100 series column department.
Figure 8: Optimisation plot for the SIMPLEX optimisation of semicarbazone 1. Optimum reaction conditions were...
Scheme 2: The reaction of pentafluoropyridine (3) with 2-(methylamino)phenol (4) to form the corresponding fu...
Figure 9: Optimisation plot for the SIMPLEX optimisation of the fused polycyclic heterocycle 5. Two optimal d...
Figure 10: SLM reactor design RD3 (left), CAD model of RD3 (right). External dimensions of RD3 are 89 (length)...
Figure 11: Optimisation plot for the SIMPLEX optimisation of semicarbazone 2. Optimum reaction conditions were...
Beilstein J. Org. Chem. 2017, 13, 65–75, doi:10.3762/bjoc.13.9
Graphical Abstract
Figure 1: Typical pilot scale single screw extruder (left) and a laboratory scale twin screw extruder (right)....
Figure 2: PTFE screw employed in single screw extrusion, with increasing root diameter (RD) from 45 mm to 95 ...
Figure 3: Modulated stainless steel intermeshing co-rotating screws employed typically in twin screw extrusio...
Scheme 1: Polymerisation of styrene using s-BuLi as an initiator.
Scheme 2: Telescoping process of the formation of polystyrene, followed by post polymerisation functionalisat...
Scheme 3: Proposed mechanism for the branching of polylactide. Adapted from [23].
Scheme 4: Chemical reaction between isocyanate and an alcohol to form polyurethane.
Figure 4: Representative diagram explaining the process involved in step growth polymerisation, which involve...
Scheme 5: Generic polycondensation reaction to produce polyamides.
Figure 5: Comparison of choline chloride/D-fructose DES prepared via twin screw extrusion (left) and conventi...
Scheme 6: Synthesis of HKUST-1, ZIF-8 and Al(fumarate)OH by twin screw extrusion. Adapted from [2].
Figure 6: Synthesis of Ni(NCS)2(PPh3)2 and [Ni(salen)] by twin screw extrusion. Adapted from [2].
Beilstein J. Org. Chem. 2016, 12, 2256–2266, doi:10.3762/bjoc.12.218
Graphical Abstract
Figure 1: The DOE “Top 10” report [2].
Figure 2: Chemical structure of isosorbide and its epimers isomannide and isoidide.
Scheme 1: Conversion of D-sorbitol to isosorbide via twofold dehydration reaction.
Scheme 2: Possible reaction mechanism for the conversion of D-sorbitol to isosorbide.
Scheme 3: Methoxycarbonylation of isosorbide via DMC chemistry.
Scheme 4: Isosorbide homo- and co-polycarbonate via melt polycondensation.
Scheme 5: Synthesis of DMI via DMC chemistry.
Scheme 6: Comparison of the reactivity of isosorbide with other secondary alcohols in methylation reaction. R...
Figure 3: Chemical structure of isosorbide and its epimers isomannide and isoidide.
Beilstein J. Org. Chem. 2016, 12, 2181–2188, doi:10.3762/bjoc.12.208
Graphical Abstract
Scheme 1: Distribution of products in the Diels–Alder reaction between cyclopentadiene and p-benzoquinone.
Figure 1: Conversion in the DAR catalysed by silica Beta zeolites and Aerosil.
Figure 2: Effect of Lewis and Brønsted acid sites in the conversion (a) and selectivity (b) of the DAR.
Figure 3: Effect of pore size in the conversion (a) and selectivity (b) of the DAR.
Figure 4: Comparison of conversion (a) and selectivity (b) of the DAR catalysed by Al-Beta zeolite and MCM-41....
Figure 5: Comparison of conversion (a) and selectivity (b) of the DAR catalysed extra-large pore 3D zeolites.
Figure 6: Effect of the Si/Al ratio in the conversion (a) and selectivity (b) of the DAR.
Figure 7: Effect of the reutilization of the catalysts in the conversion (a) and selectivity (b) of the DAR.
Beilstein J. Org. Chem. 2016, 12, 2046–2054, doi:10.3762/bjoc.12.193
Graphical Abstract
Scheme 1: Synthesis of menthol.
Scheme 2: Synthesis of para-menthane-3,8-diol.
Scheme 3: Synthesis of para-menthane diester derivatives.
Figure 1: PMD conversion using stoichiometric quantities of acetic anhydride.
Figure 2: Product distribution as a function of time.
Figure 3: Product distribution as a function of time.
Figure 4: Effect of molar ratio in product distribution.
Scheme 4: Synthesis of para-menthane mono-ester derivatives.
Beilstein J. Org. Chem. 2016, 12, 1987–2004, doi:10.3762/bjoc.12.186
Graphical Abstract
Scheme 1: PTSA-catalyzed diazotization and azo coupling reaction.
Scheme 2: Ferric hydrogen sulfate (FHS) catalyzed azo compound synthesis.
Scheme 3: Synthesis of azo compounds in the presence of silica supported boron trifluoride.
Scheme 4: Phase transfer catalyzed azo coupling of 5-methylresorcinol in microreactors.
Scheme 5: Synthesis of yellow pigment 12 in a micro-mixer apparatus.
Scheme 6: Continuous flow synthesis of Sudan II azo dye in LTF-MS microreactors.
Figure 1: pH profile plot at constant flow rate of 0.03 mL/min.
Figure 2: pH profile plot at a constant flow rate of 0.7 mL/min.
Scheme 7: Azo coupling reaction under acidic conditions.
Figure 3: pH profile plot at a constant flow rate of 0.03 mL/min.
Figure 4: pH profile plot at constant flow rate of 0.7 mL/min.
Figure 5: Temperature profile plot at constant pH 5.66.
Figure 6: Schematic representation of the microreactor set up.
Figure 7: Schematic representation of the microreactor set up.
Figure 8: Scaled up microreactor set up: PTFE tubing i.d. 1.5 mm a) Chemyx Fusion 100 classic syringe pump, b...
Beilstein J. Org. Chem. 2016, 12, 1798–1811, doi:10.3762/bjoc.12.170
Graphical Abstract
Figure 1: The challenge of mixing the three dispersed entities gas, liquid, and light for photochemical appli...
Scheme 1: Mutual interdependencies of critical reaction and reactor parameters.
Scheme 2: Blueprint of the home-built microflow photoreactor; schematic illustration of the reactor setup wit...
Figure 2: Total absorbance of methylene blue solutions in acetonitrile according to the Beer-Lambert law: Eλ ...
Figure 3: Red (λmax = 633 nm), blue (λmax = 448 nm), green (λmax = 520 nm) and white (λmax = 620 nm) LEDs mou...
Figure 4: Overlap of absorption spectrum of methylene blue in acetonitrile and emission spectra of reasonably...
Figure 5: Emission spectra of different LEDs; red (λmax = 633 nm), blue (λmax = 448 nm), green (λmax = 520 nm...
Scheme 3: Slug flow conditions of two-phase gas-liquid mixtures. Photograph of a slug flow of a solution of m...
Figure 6: Photograph of the operating flow reactor, irradiated with white LEDs, filled with a solution of met...
Scheme 4: Schematic illustration of a reactor tube (length l, inner diameter d) and pressure gradient Δp acco...
Scheme 5: Reaction types of organic molecules with singlet oxygen.
Figure 7: Home-made flow reactor and peripheral devices for photochemical reactions at light/liquid/gas inter...
Scheme 6: Photooxygenation of N-methyl-1,2,3,6-tetrahydrophthalimide and reductive work-up to alcohol 3a.
Figure 8: Conversion vs methylene blue sensitizer concentration. Reactions at constant flow rates in acetonit...
Figure 9: Reaction progress at different residence times in flow and batch reactions. Flow: reactions at diff...
Scheme 7: Oxidation of N-methyl-1,2,3,6-tetrahydro-3-acetamidophthalimide and reductive work-up to alcohol 3b....
Beilstein J. Org. Chem. 2016, 12, 1647–1748, doi:10.3762/bjoc.12.162
Graphical Abstract
Figure 1: The named transformations considered in this review.
Scheme 1: The Baeyer–Villiger oxidation.
Scheme 2: The general mechanism of the peracid-promoted Baeyer–Villiger oxidation.
Scheme 3: General mechanism of the Lewis acid-catalyzed Baeyer–Villiger rearrangement.
Scheme 4: The theoretically studied mechanism of the BV oxidation reaction promoted by H2O2 and the Lewis aci...
Scheme 5: Proton movements in the transition states of the Baeyer–Villiger oxidation.
Scheme 6: The dependence of the course of the Baeyer–Villiger oxidation on the type of O–O-bond cleavage in t...
Scheme 7: The acid-catalyzed Baeyer–Villiger oxidation of cyclic epoxy ketones 22.
Scheme 8: Oxidation of isophorone oxide 29.
Scheme 9: Synthesis of acyl phosphate 32 from acyl phosphonate 31.
Scheme 10: Synthesis of aflatoxin B2 (36).
Scheme 11: The Baeyer–Villiger rearrangement of ketones 37 to lactones 38.
Scheme 12: Synthesis of 3,4-dimethoxybenzoic acid (40) via Baeyer–Villiger oxidation.
Scheme 13: Oxone transforms α,β-unsaturated ketones 43 into vinyl acetates 44.
Scheme 14: The Baeyer–Villiger oxidation of ketones 45 using diaryl diselenide and hydrogen peroxide.
Scheme 15: Baeyer–Villiger oxidation of (E)-2-methylenecyclobutanones.
Scheme 16: Oxidation of β-ionone (56) by H2O2/(BnSe)2 with formation of (E)-2-(2,6,6-trimethylcyclohex-1-en-1-...
Scheme 17: The mechanism of oxidation of ketones 58a–f by hydrogen peroxide in the presence of arsonated polys...
Scheme 18: Oxidation of ketone (58b) by H2O2 to 6-methylcaprolactone (59b) catalyzed by Pt complex 66·BF4.
Scheme 19: Oxidation of ketones 67 with H2O2 in the presence of [(dppb}Pt(µ-OH)]22+.
Scheme 20: The mechanism of oxidation of ketones 67 in the presence of [(dppb}Pt(µ-OH)]22+ and H2O2.
Scheme 21: Oxidation of benzaldehydes 69 in the presence of the H2O2/MeReO3 system.
Scheme 22: Oxidation of acetophenones 72 in the presence of the H2O2/MeReO3 system.
Scheme 23: Baeyer–Villiger oxidation of 2-adamantanone (45c) in the presence of Sn-containing mesoporous silic...
Scheme 24: Aerobic Baeyer–Villiger oxidation of ketones 76 using metal-free carbon.
Scheme 25: A regioselective Baeyer-Villiger oxidation of functionalized cyclohexenones 78 into a dihydrooxepin...
Scheme 26: The oxidation of aldehydes and ketones 80 by H2O2 catalyzed by Co4HP2Mo15V3O62.
Scheme 27: The cleavage of ketones 82 with hydrogen peroxide in alkaline solution.
Scheme 28: Oxidation of ketones 85 to esters 86 with H2O2–urea in the presence of KHCO3.
Scheme 29: Mechanism of the asymmetric oxidation of cyclopentane-1,2-dione 87a with the Ti(OiPr)4/(+)DET/t-BuO...
Scheme 30: The oxidation of cis-4-tert-butyl-2-fluorocyclohexanone (93) with m-chloroperbenzoic acid.
Scheme 31: The mechanism of the asymmetric oxidation of 3-substituted cyclobutanone 96a in the presence of chi...
Scheme 32: Enantioselective Baeyer–Villiger oxidation of cyclic ketones 98.
Scheme 33: Regio- and enantioselective Baeyer–Villiger oxidation of cyclic ketones 101.
Scheme 34: The proposed mechanism of the Baeyer–Villiger oxidation of acetal 105f.
Scheme 35: Synthesis of hydroxy-10H-acridin-9-one 117 from tetramethoxyanthracene 114.
Scheme 36: The Baeyer–Villiger oxidation of the fully substituted pyrrole 120.
Scheme 37: The Criegee rearrangement.
Scheme 38: The mechanism of the Criegee reaction of a peracid with a tertiary alcohol 122.
Scheme 39: Criegee rearrangement of decaline ethylperoxoate 127 into ketal 128.
Scheme 40: The ionic cleavage of 2-methoxy-2-propyl perester 129.
Scheme 41: The Criegee rearrangement of α-methoxy hydroperoxide 136.
Scheme 42: Synthesis of enol esters and acetals via the Criegee rearrangement.
Scheme 43: Proposed mechanism of the transformation of 1-hydroperoxy-2-oxabicycloalkanones 147a–d.
Scheme 44: Transformation of 3-hydroxy-1,2-dioxolanes 151 into diketone derivatives 152.
Scheme 45: Criegee rearrangement of peroxide 153 with the mono-, di-, and tri-O-insertion.
Scheme 46: The sequential Criegee rearrangements of adamantanes 157a,b.
Scheme 47: Synthesis of diaryl carbonates 160a–d from triarylmethanols 159a–d through successive oxygen insert...
Scheme 48: The synthesis of sesquiterpenes 162 from ketone 161 with a Criegee rearrangement as one key step.
Scheme 49: Synthesis of trans-hydrindan derivatives 164, 165.
Scheme 50: The Hock rearrangement.
Scheme 51: The general scheme of the cumene process.
Scheme 52: The Hock rearrangement of aliphatic hydroperoxides.
Scheme 53: The mechanism of solvolysis of brosylates 174a–c and spiro cyclopropyl carbinols 175a–c in THF/H2O2....
Scheme 54: The fragmentation mechanism of hydroperoxy acetals 178 to esters 179.
Scheme 55: The acid-catalyzed rearrangement of phenylcyclopentyl hydroperoxide 181.
Scheme 56: The peroxidation of tertiary alcohols in the presence of a catalytic amount of acid.
Scheme 57: The acid-catalyzed reaction of bicyclic secondary alcohols 192 with hydrogen peroxide.
Scheme 58: The photooxidation of 5,6-disubstituted 3,4-dihydro-2H-pyrans 196.
Scheme 59: The oxidation of tertiary alcohols 200a–g, 203a,b, and 206.
Scheme 60: Transformation of functional peroxide 209 leading to 2,3-disubstitued furans 210 in one step.
Scheme 61: The synthesis of carbazoles 213 via peroxide rearrangement.
Scheme 62: The construction of C–N bonds using the Hock rearrangement.
Scheme 63: The synthesis of moiety 218 from 217 which is a structural motif in the antitumor–antibiotic of CC-...
Scheme 64: The in vivo oxidation steps of cholesterol (219) by singlet oxygen.
Scheme 65: The proposed mechanism of the rearrangement of cholesterol-5α-OOH 220.
Scheme 66: Photochemical route to artemisinin via Hock rearrangement of 223.
Scheme 67: The Kornblum–DeLaMare rearrangement.
Scheme 68: Kornblum–DeLaMare transformation of 1-phenylethyl tert-butyl peroxide (225).
Scheme 69: The synthesis 4-hydroxyenones 230 from peroxide 229.
Scheme 70: The Kornblum–DeLaMare rearrangement of peroxide 232.
Scheme 71: The reduction of peroxide 234.
Scheme 72: The Kornblum–DeLaMare rearrangement of endoperoxide 236.
Scheme 73: The rearrangement of peroxide 238 under Kornblum–DeLaMare conditions.
Scheme 74: The proposed mechanism of rearrangement of peroxide 238.
Scheme 75: The Kornblum–DeLaMare rearrangement of peroxides 242a,b.
Scheme 76: The base-catalyzed rearrangements of bicyclic endoperoxides having electron-withdrawing substituent...
Scheme 77: The base-catalyzed rearrangements of bicyclic endoperoxides 249a,b having electron-donating substit...
Scheme 78: The base-catalyzed rearrangements of bridge-head substituted bicyclic endoperoxides 251a,b.
Scheme 79: The Kornblum–DeLaMare rearrangement of hydroperoxide 253.
Scheme 80: Synthesis of β-hydroxy hydroperoxide 254 from endoperoxide 253.
Scheme 81: The amine-catalyzed rearrangement of bicyclic endoperoxide 263.
Scheme 82: The base-catalyzed rearrangement of meso-endoperoxide 268 into 269.
Scheme 83: The photooxidation of 271 and subsequent Kornblum–DeLaMare reaction.
Scheme 84: The Kornblum–DeLaMare rearrangement as one step in the oxidation reaction of enamines.
Scheme 85: The Kornblum–DeLaMare rearrangement of 3,5-dihydro-1,2-dioxenes 284, 1,2-dioxanes 286, and tert-but...
Scheme 86: The Kornblum–DeLaMare rearrangement of epoxy dioxanes 290a–d.
Scheme 87: Rearrangement of prostaglandin H2 292.
Scheme 88: The synthesis of epicoccin G (297).
Scheme 89: The Kornblum–DeLaMare rearrangement used in the synthesis of phomactin A.
Scheme 90: The Kornblum–DeLaMare rearrangement in the synthesis of 3H-quinazolin-4-one 303.
Scheme 91: The Kornblum–DeLaMare rearrangement in the synthesis of dolabriferol (308).
Scheme 92: Sequential transformation of 3-substituted 2-pyridones 309 into 3-hydroxypyridine-2,6-diones 311 in...
Scheme 93: The Kornblum–DeLaMare rearrangement of peroxide 312 into hydroxy enone 313.
Scheme 94: The Kornblum–DeLaMare rearrangement in the synthesis of polyfunctionalized carbonyl compounds 317.
Scheme 95: The Kornblum–DeLaMare rearrangement in the synthesis of (Z)-β-perfluoroalkylenaminones 320.
Scheme 96: The Kornblum–DeLaMare rearrangement in the synthesis of γ-ketoester 322.
Scheme 97: The Kornblum–DeLaMare rearrangement in the synthesis of diterpenoids 326 and 328.
Scheme 98: The synthesis of natural products hainanolidol (331) and harringtonolide (332) from peroxide 329.
Scheme 99: The synthesis of trans-fused butyrolactones 339 and 340.
Scheme 100: The synthesis of leucosceptroid C (343) and leucosceptroid P (344) via the Kornblum–DeLaMare rearra...
Scheme 101: The Dakin oxidation of arylaldehydes or acetophenones.
Scheme 102: The mechanism of the Dakin oxidation.
Scheme 103: A solvent-free Dakin reaction of aromatic aldehydes 356.
Scheme 104: The organocatalytic Dakin oxidation of electron-rich arylaldehydes 358.
Scheme 105: The Dakin oxidation of electron-rich arylaldehydes 361.
Scheme 106: The Dakin oxidation of arylaldehydes 358 in water extract of banana (WEB).
Scheme 107: A one-pot approach towards indolo[2,1-b]quinazolines 364 from indole-3-carbaldehydes 363 through th...
Scheme 108: The synthesis of phenols 367a–c from benzaldehydes 366a-c via acid-catalyzed Dakin oxidation.
Scheme 109: Possible transformation paths of the highly polarized boric acid coordinated H2O2–aldehyde adduct 3...
Scheme 110: The Elbs oxidation of phenols 375 to hydroquinones.
Scheme 111: The mechanism of the Elbs persulfate oxidation of phenols 375 affording p-hydroquinones 376.
Scheme 112: Oxidation of 2-pyridones 380 under Elbs persulfate oxidation conditions.
Scheme 113: Synthesis of 3-hydroxy-4-pyridone (384) via an Elbs oxidation of 4-pyridone (382).
Scheme 114: The Schenck rearrangement.
Scheme 115: The Smith rearrangement.
Scheme 116: Three main pathways of the Schenck rearrangement.
Scheme 117: The isomerization of hydroperoxides 388 and 389.
Scheme 118: Trapping of dioxacyclopentyl radical 392 by oxygen.
Scheme 119: The hypothetical mechanism of the Schenck rearrangement of peroxide 394.
Scheme 120: The autoxidation of oleic acid (397) with the use of labeled isotope 18O2.
Scheme 121: The rearrangement of 18O-labeled hydroperoxide 400 under an atmosphere of 16O2.
Scheme 122: The rearrangement of the oleate-derived allylic hydroperoxides (S)-421 and (R)-425.
Scheme 123: Mechanisms of Schenck and Smith rearrangements.
Scheme 124: The rearrangement and cyclization of 433.
Scheme 125: The Wieland rearrangement.
Scheme 126: The rearrangement of bis(triphenylsilyl) 439 or bis(triphenylgermyl) 441 peroxides.
Scheme 127: The oxidative transformation of cyclic ketones.
Scheme 128: The hydroxylation of cyclohexene (447) in the presence of tungstic acid.
Scheme 129: The oxidation of cyclohexene (447) under the action of hydrogen peroxide.
Scheme 130: The reaction of butenylacetylacetone 455 with hydrogen peroxide.
Scheme 131: The oxidation of bridged 1,2,4,5-tetraoxanes.
Scheme 132: The proposed mechanism for the oxidation of bridged 1,2,4,5-tetraoxanes.
Scheme 133: The rearrangement of ozonides.
Scheme 134: The acid-catalyzed oxidative rearrangement of malondialdehydes 462 under the action of H2O2.
Scheme 135: Pathways of the Lewis acid-catalyzed cleavage of dialkyl peroxides 465 and ozonides 466.
Scheme 136: The mechanism of the transformation of (tert-butyldioxy)cyclohexanedienones 472.
Scheme 137: The synthesis of Vitamin K3 from 472a.
Scheme 138: Proposed mechanism for the transformation of 478d into silylated endoperoxide 479d.
Scheme 139: The rearrangement of hydroperoxide 485 to form diketone 486.
Scheme 140: The base-catalyzed rearrangement of cyclic peroxides 488a–g.
Scheme 141: Synthesis of chiral epoxides and aldols from peroxy hemiketals 491.
Scheme 142: The multistep transformation of (R)-carvone (494) to endoperoxides 496a–e.
Scheme 143: The decomposition of anthracene endoperoxide 499.
Scheme 144: Synthesis of esters 503 from aldehydes 501 via rearrangement of peroxides 502.
Scheme 145: Two possible paths for the base-promoted decomposition of α-azidoperoxides 502.
Scheme 146: The Story decomposition of cyclic diperoxide 506a.
Scheme 147: The Story decomposition of cyclic triperoxide 506b.
Scheme 148: The thermal rearrangement of endoperoxides A into diepoxides B.
Scheme 149: The transformation of peroxide 510 in the synthesis of stemolide (511).
Scheme 150: The possible mechanism of the rearrangement of endoperoxide 261g.
Scheme 151: The photooxidation of indene 517.
Scheme 152: The isomerization of ascaridole (523).
Scheme 153: The isomerization of peroxide 525.
Scheme 154: The thermal transformation of endoperoxide 355.
Scheme 155: The photooxidation of cyclopentadiene (529) at a temperature higher than 0 °C.
Scheme 156: The thermal rearrangement of endoperoxides 538a,b.
Scheme 157: The transformation of peroxides 541.
Scheme 158: The thermal rearrangements of strained cyclic peroxides.
Scheme 159: The thermal rearrangement of diacyl peroxide 551 in the synthesis of C4-epi-lomaiviticin B core 553....
Scheme 160: The 1O2 oxidation of tryptophan (554) and rearrangement of dioxetane intermediate 555.
Scheme 161: The Fe(II)-promoted cleavage of aryl-substituted bicyclic peroxides.
Scheme 162: The proposed mechanism of the Fe(II)-promoted rearrangement of 557a–c.
Scheme 163: The reaction of dioxolane 563 with Fe(II) sulfate.
Scheme 164: Fe(II)-promoted rearrangement of 1,2-dioxane 565.
Scheme 165: Fe(II) cysteinate-promoted rearrangement of 1,2-dioxolane 568.
Scheme 166: The transformation of 1,2-dioxanes 572a–c under the action of FeCl2.
Scheme 167: Fe(II) cysteinate-promoted transformation of tetraoxane 574.
Scheme 168: The CoTPP-catalyzed transformation of bicyclic endoperoxides 600a–d.
Scheme 169: The CoTPP-catalyzed transformation of epoxy-1,2-dioxanes.
Scheme 170: The Ru(II)-catalyzed reactions of 1,4-endoperoxide 261g.
Scheme 171: The Ru(II)-catalyzed transformation as a key step in the synthesis of elyiapyrone A (610) from 1,4-...
Scheme 172: Peroxides with antimalarial activity.
Scheme 173: The interaction of iron ions with artemisinin (616).
Scheme 174: The interaction of FeCl2 with 1,2-dioxanes 623, 624.
Scheme 175: The mechanism of reaction 623 and 624 with Fe(II)Cl2.
Scheme 176: The reaction of bicyclic natural endoperoxides G3-factors 631–633 with FeSO4.
Scheme 177: The transformation of terpene cardamom peroxide 639.
Scheme 178: The different ways of the cleavage of tetraoxane 643.
Scheme 179: The LC–MS analysis of interaction of tetraoxane 646 with iron(II)heme 647.
Scheme 180: The rearrangement of 3,6-epidioxy-1,10-bisaboladiene (EDBD, 649).
Scheme 181: Easily oxidized substrates.
Scheme 182: Biopathway of synthesis of prostaglandins.
Scheme 183: The reduction and rearrangements of isoprostanes.
Scheme 184: The partial mechanism for linoleate 658 oxidation.
Scheme 185: The transformation of lipid hydroperoxide.
Scheme 186: The acid-catalyzed cleavage of the product from free-radical oxidation of cholesterol (667).
Scheme 187: Two pathways of catechols oxidation.
Scheme 188: Criegee-like or Hock-like rearrangement of the intermediate hydroperoxide 675 in dioxygenase enzyme...
Scheme 189: Carotinoides 679 cleavage by carotenoid cleavage dioxygenases.
Beilstein J. Org. Chem. 2016, 12, 1–4, doi:10.3762/bjoc.12.1
Graphical Abstract
Figure 1: Examples of naturally-occurring and synthetic bioactive (amidoalkyl)pyridines.
Scheme 1: Discovery of the azlactone arylation/decarboxylative hydrolysis approach to 2-(1-amidoalkyl)pyridin...
Scheme 2: Substrate scope of the direct amidoalkylation of pyridine N-oxides.
Beilstein J. Org. Chem. 2015, 11, 2408–2417, doi:10.3762/bjoc.11.262
Graphical Abstract
Scheme 1: Two-phase reaction of N,N-dialkylamine and sodium hypochlorite.
Figure 1: Calorimeter trace for the single phase reaction of morpholine (aq) and NaOCl (aq). Q Comp: compensa...
Figure 2: Meso-scale static mixer set-up for continuous N-chloramine formation. (a) Pumps, (b) reagent soluti...
Figure 3: Effect of static mixers on biphasic solution.
Figure 4: Progress of reaction for continuous formation of N-chloromorpholine. Morpholine (toluene) 0.9 M 1 m...
Figure 5: CSTR set-up for N-chloramine formation. (a) Syringe pump, (b) collection vessels, (c) reactor (50 m...
Figure 6: Interior of 50 mL CSTR.
Beilstein J. Org. Chem. 2015, 11, 1713–1720, doi:10.3762/bjoc.11.186
Graphical Abstract
Figure 1: Library generation of P450cam[Tyr96Phe]-RhFRed. Active site of the P450cam-RhFRed variant Tyr96Phe ...
Figure 2: Radar plots illustrating the substrate acceptance of P450cam-RhFRed variants from library I. Colour...
Figure 3: Yields of alcohols (R,S)-9-11 (grey bars) and ketone products 13–15 (blue bars) in sub-pools of lib...
Beilstein J. Org. Chem. 2015, 11, 1509–1513, doi:10.3762/bjoc.11.164
Graphical Abstract
Figure 1: The structure of mianserin 1 and epinastine 2.
Scheme 1: Enantioselective synthesis of (S)-(+)-mianserin.
Figure 2: Catalysts used in ATH.
Figure 3: The ORTEP diagram for X-ray analysis of compound (S)-7.
Scheme 2: Enantioselective synthesis of (S)-(+)-epinastine.
Beilstein J. Org. Chem. 2015, 11, 1340–1351, doi:10.3762/bjoc.11.144
Graphical Abstract
Scheme 1: Reaction of carbon dioxide with epoxide to yield alternating polycarbonates, polyethercarbonates or...
Scheme 2: Epoxide and CO2 copolymerisation by homogeneous Cr(III)– and Al(III)–salen complexes.
Figure 1: The tri-coordinated di-iminate zinc–alkoxide complex [(BDI)ZnOCH3].
Scheme 3: Heterogeneous zinc dicarboxylates for the copolymerisation of CO2 and epoxides. (* = End group of p...
Scheme 4: Backbiting mechanism for the formation of cyclic carbonates.
Scheme 5: Two-step pathway for the cycloaddition of propylene oxide and CO2 in the ionic liquid 1-butyl-3-met...
Scheme 6: Formation of copper(I) cyanoacetate for the activation of CO2.
Scheme 7: Activation of CO2 by nucleophilic attack of bromide in the Re(I)-catalysed cycloaddition.
Scheme 8: Direct catalytic carboxylation of aliphatic compounds and arenes by rhodium(I)– and ruthenium(II)–p...
Scheme 9: Insertion of carbon dioxide into a metal–oxygen bond via a cyclic four-membered transition state. R...
Scheme 10: Facile CO2 uptake by zinc(II)–tetraazacycloalkanes.
Figure 2: The [(2-hydroxyethoxy)CoIII(salen)(L)] complex chosen as catalyst model for the calculations; 1: R1...
Figure 3: The two most relevant configurations of [(2-hydroxyethoxy)CoIII(salen)(L)] complexes. The left-hand...
Figure 4: Carbon dioxide insertion into the cobalt(III)–alkoxide bond of [(2-hydroxyethoxy)CoIII(salen)(L)] c...
Figure 5: Energy relationship between the activation barrier and the reaction energy of the CO2 incorporation...
Beilstein J. Org. Chem. 2015, 11, 1194–1219, doi:10.3762/bjoc.11.134
Graphical Abstract
Figure 1: Pharmaceutical structures targeted in early flow syntheses.
Scheme 1: Flow synthesis of 6-hydroxybuspirone (9). Inserted photograph reprinted with permission from [45]. Copy...
Figure 2: Configuration of a baffled reactor tube (left) and its schematic working principle (right).
Scheme 2: McQuade’s flow synthesis of ibuprofen (16).
Scheme 3: Jamison’s flow synthesis of ibuprofen sodium salt (17).
Scheme 4: Flow synthesis of imatinib (23).
Scheme 5: Flow synthesis of the potent 5HT1B antagonist 28.
Scheme 6: Flow synthesis of a selective δ-opioid receptor agonist 33.
Scheme 7: Flow synthesis of a casein kinase I inhibitor library (38).
Scheme 8: Flow synthesis of fluoxetine (46).
Scheme 9: Flow synthesis of artemisinin (55).
Scheme 10: Telescoped flow synthesis of artemisinin (55) and derivatives (62–64).
Scheme 11: Flow approach towards AZD6906 (65).
Scheme 12: Pilot scale flow synthesis of key intermediate 73.
Scheme 13: Semi-flow synthesis of vildagliptine (77).
Scheme 14: Pilot scale asymmetric flow hydrogenation towards 83. Inserted photograph reprinted with permission...
Figure 3: Schematic representation of the ‘tube-in-tube’ reactor.
Scheme 15: Flow synthesis of fanetizole (87) via tube-in-tube system.
Scheme 16: Flow synthesis of diphenhydramine.HCl (92).
Scheme 17: Flow synthesis of rufinamide (95).
Scheme 18: Large scale flow synthesis of rufinamide precursor 102.
Scheme 19: First stage in the flow synthesis of meclinertant (103).
Scheme 20: Completion of the flow synthesis of meclinertant (103).
Scheme 21: Flow synthesis of olanzapine (121) utilising inductive heating techniques.
Scheme 22: Flow synthesis of amitriptyline·HCl (127).
Scheme 23: Flow synthesis of E/Z-tamoxifen (132) using peristaltic pumping modules.
Figure 4: Container sized portable mini factory (photograph credit: INVITE GmbH, Leverkusen Germany).
Scheme 24: Flow synthesis of imidazo[1,2-a]pyridines 136 linked to frontal affinity chromatography (FAC).
Figure 5: Structures of zolpidem (142) and alpidem (143).
Scheme 25: Synthesis and screening loops in the discovery of new Abl kinase inhibitors.
Figure 6: Schotten–Baumann approach towards LY573636.Na (147).
Scheme 26: Pilot scale flow synthesis of LY2886721 (146).
Scheme 27: Continuous flow manufacture of alikiren hemifumarate 152.
Beilstein J. Org. Chem. 2014, 10, 1166–1196, doi:10.3762/bjoc.10.117
Graphical Abstract
Scheme 1: Pioneer works of Atherton, Openshaw and Todd reporting on the synthesis of phosphoramidate starting...
Scheme 2: Mechanisms 1 (i) and 2 (ii) suggested by Atherton and Todd in 1945; adapted from [1].
Scheme 3: Two reaction pathways (i and ii) to produce chlorophosphate 2. Charge-transfer complex observed whe...
Scheme 4: Mechanism of the Atherton–Todd reaction with dimethylphosphite according to Roundhill et al. (adapt...
Scheme 5: Synthesis of dialkyl phosphate from dialkyl phosphite (i) and identification of chloro- and bromoph...
Scheme 6: Synthesis of chiral phosphoramidate with trichloromethylphosphonate as the suggested intermediate (...
Scheme 7: Selection of results that address the question of the stereochemistry of the AT reaction (adapted f...
Scheme 8: Synthesis of phenoxy spirophosphorane by the AT reaction (adapted from [34]).
Scheme 9: Suggested mechanism of the Atherton–Todd reaction, (i) and (ii) formation of chlorophosphate with a...
Scheme 10: AT reaction in biphasic conditions (adapted from [38]).
Scheme 11: AT reaction with iodoform as halide source (adapted from [37]).
Scheme 12: AT reaction with phenol at low temperature in the presence of DMAP (adapted from [40]).
Scheme 13: Synthesis of a triphosphate by the AT reaction starting with the preparation of chlorophosphate (ad...
Scheme 14: AT reaction with sulfonamide (adapted from [42]).
Scheme 15: Synthesis of a styrylphosphoramidate starting from the corresponding aniline (adapted from [43]).
Scheme 16: Use of hydrazine as nucleophile in AT reactions (adapted from [48]).
Scheme 17: AT reaction with phenol as a nucleophilic species; synthesis of dioleyl phosphate-substituted couma...
Scheme 18: Synthesis of β-alkynyl-enolphosphate from allenylketone with AT reaction (adapted from [58]).
Scheme 19: Synthesis of pseudohalide phosphate by using AT reaction (adapted from [67]).
Scheme 20: AT reaction with hydrospirophosphorane with insertion of CO2 in the product (adapted from [69]).
Scheme 21: AT reaction with diaryl phosphite (adapted from [70]).
Scheme 22: AT reaction with O-alkyl phosphonite (adapted from [71]).
Scheme 23: Use of phosphinous acid in AT reactions (adapted from [72]).
Scheme 24: AT reaction with secondary phosphinethiooxide (adapted from [76]).
Scheme 25: Use of H-phosphonothioate in the AT reaction (adapted from [78]).
Scheme 26: AT-like reaction with CuI as catalyst and without halide source (adapted from [80]).
Scheme 27: Reduction of phenols after activation as phosphate derivatives (adapted from [81] i ; [82], ii; and [83], iii).
Scheme 28: Synthesis of medium and large-sized nitrogen-containing heterocycles (adapted from [85]).
Scheme 29: Synthesis of arylstannane from aryl phosphate prepared by an AT reaction (adapted from [86]).
Scheme 30: Synthesis and use of aryl dialkyl phosphate for the synthesis of biaryl derivatives (adapted from [89])....
Scheme 31: Synthesis of aryl dialkyl phosphate by an AT reaction from phenol and subsequent rearrangement yiel...
Scheme 32: Selected chiral phosphoramidates used as organocatalyst; i) chiral phosphoramidate used in the pion...
Scheme 33: Determination of ee of H-phosphinate by the application of the AT reaction with a chiral amine (ada...
Scheme 34: Chemical structure of selected flame retardants synthesized by AT reactions; (BDE: polybrominated d...
Scheme 35: Transformation of DOPO (i) and synthesis of polyphosphonate (ii) by the AT reaction (adapted from [117] ...
Scheme 36: Synthesis of lipophosphite (bisoleyl phosphite) and cationic lipophosphoramidate with an AT reactio...
Scheme 37: Use of AT reactions to produce cationic lipids characterized by a trimethylphosphonium, trimethylar...
Scheme 38: Cationic lipid synthesized by the AT reaction illustrating the variation of the structure of the li...
Scheme 39: Helper lipids for nucleic acid delivery synthesized with the AT reaction (adapted from [130]).
Scheme 40: AT reaction used to produce red/ox-sensitive cationic lipids (adapted from [135]).
Scheme 41: Alkyne and azide-functionalized phosphoramidate synthesized by AT reactions,(i); illustration of so...
Scheme 42: Cationic lipids exhibiting bactericidal action – arrows indicate the bond formed by the AT reaction...
Scheme 43: β-Cyclodextrin-based lipophosphoramidates (adapted from [138]).
Scheme 44: Polyphosphate functionalized by an AT reaction (adapted from [139]).
Scheme 45: Synthesis of zwitterionic phosphocholine-bound chitosan (adapted from [142]).
Scheme 46: Synthesis of AZT-based prodrug via an AT reaction (adapted from [143]).
Beilstein J. Org. Chem. 2013, 9, 2852–2861, doi:10.3762/bjoc.9.321
Graphical Abstract
Scheme 1: Synthesis of star-shaped triphenylene discotic liquid crystalline trimer 4.
Scheme 2: Synthesis of star-shaped triphenylene discotic liquid crystalline trimers 5a–c.
Figure 1: Optical photomicrographs of the triphenylene DLC monomers. (A) 2 at 40 °C; (B) 3a at 45 °C; (C) 3b ...
Figure 2: Optical photomicrographs of the triphenylene DLC trimers. (A) 4 at 70 °C; (B) 5b at 85 °C; (C) 5c a...
Figure 3: The DSC traces of the triphenylene DLC monomers and trimers. (A) 2nd heating traces; (B) 1st coolin...
Figure 4: Powder X-ray diffraction patterns of the DLC trimmers 4, 5b and 5c at room temperature.
Figure 5: X-ray diffraction profiles of 4 at different temperatures.
Beilstein J. Org. Chem. 2013, 9, 2015–2021, doi:10.3762/bjoc.9.237
Graphical Abstract
Scheme 1: General [2 + 2]-cycloaddition of furanones with alkenes.
Figure 1: Rayonet chamber reactor (RMR-600; Southern New England) with quartz test tubes. A 10 AU-cent coin i...
Figure 2: Microcapillary reactor. (a) Setup with inserted μ-capillary unit. A 10 AU-cent coin is shown for co...
Figure 3: (a) UV-spectrum of 1 (in MeCN) vs emission spectrum of the UVC lamp. (b) Light-penetration profile ...
Scheme 2: [2 + 2]-Cycloadditions of furanone 1 with cyclopentene (2).
Scheme 3: [2 + 2]-Cycloadditions of furanone 1 with 2,3-dimethylbut-2-ene (4).
Beilstein J. Org. Chem. 2013, 9, 1102–1110, doi:10.3762/bjoc.9.122
Graphical Abstract
Figure 1: N-ethylhexyl-substituted (1) [20] and target free N–H (2) cyanopyridone structures.
Scheme 1: Synthesis of the cyanopyridone 2, reagents and conditions: (i) Pd(PPh3)4, Cs2CO3, toluene, reflux, ...
Figure 2: (a) Chloroform (solid line) and thin-film (dashed line) UV–vis absorption and emission spectra and ...
Figure 3: The concentration dependence of (a) the NH 1H NMR chemical shift and (b) the vinyl proton chemical ...
Figure 4: AFM height image of observed nanostructures of films drop cast from (a) 10 mg/mL and (b) 1 mg/mL ch...
Figure 5: Dimeric structures of 2. (a) centrosymmetric dimer of 2; (b) bond-rotated centrosymmetric dimer of 2...
Figure 6: Schematic representation of self-complementary interactions leading to one-dimensional chains.
Beilstein J. Org. Chem. 2012, 8, 2025–2052, doi:10.3762/bjoc.8.229
Graphical Abstract
Figure 1: An immersion-well batch reactor with 125 W medium pressure Hg lamp.
Figure 2: Transmission profile of a 0.05 M solution, ε = 200 M−1 cm−1.
Figure 3: Schematic of a typical microflow photochemical reactor (above) and detail of a triple-channel micro...
Figure 4: Schematic of a typical macroflow photochemical reactor (above) and images of the FEP photochemical ...
Scheme 1: [2 + 2] photocycloadditions of enones with enol derivatives.
Scheme 2: Competing reactions in an intramolecular [2 + 2] photocycloaddition.
Scheme 3: Diastereocontrolled cycloaddition of a cyclic enone with cyclopentene.
Scheme 4: Comparison of yields and reaction times for a batch reactor with a microflow system.
Scheme 5: Intramolecular [2 + 2] photocycloaddition.
Scheme 6: Paterno–Büchi reaction of benzophenone with an allylic alcohol.
Scheme 7: Photooxygenation of cyclopentadiene.
Scheme 8: Preparation of the anthelmintic ascaridole 23.
Scheme 9: Production of rose oxide 27 from (−)-β-citronellol (24).
Scheme 10: Photocatalytic alkylation of benzylamine.
Scheme 11: Photocatalytic reduction of 4-nitroacetophenone.
Scheme 12: Conversion of L-lysine to L-pipecolinic acid.
Scheme 13: Photocatalytic hydrodehalogenation.
Scheme 14: Photocatalytic aza-Henry reactions.
Scheme 15: Photocatalytic α-alkylation of aliphatic ketones.
Scheme 16: Decarboxylative photochemical additions.
Scheme 17: Photochemical addition of isopropanol to furanones.
Scheme 18: Photochemical addition of methanol to limonene.
Scheme 19: Light-promoted reduction of flavone.
Scheme 20: Photoreduction of benzophenone with benzhydrol.
Scheme 21: Barton reaction in a microflow system.
Scheme 22: Microflow synthesis of vitamin D3.
Scheme 23: photochemical chlorination of cyclohexane.
Scheme 24: photochemical cyanation of pyrene.
Scheme 25: Intermolecular [2 + 2] cycloaddition of maleimide (76) and intramolecular [2 + 2] cycloaddition of ...
Scheme 26: Intramolecular [5 + 2] cycloaddition of maleimide under flow conditions.
Scheme 27: Intramolecular [5 + 2] cycloaddition as a key step in the synthesis of (±)-neostenine.
Scheme 28: In situ generation of a thioaldehyde by photolysis of a phenacyl sulfide.
Scheme 29: Photodimerisation of maleic anhydride.
Scheme 30: [2 + 2] cycloaddition of a chiral enone with ethylene.
Scheme 31: Intramolecular [2 + 2] cycloaddition of a cyclopentenone.
Scheme 32: Photochemical Wolff rearrangement and cyclisation to β-lactams.
Scheme 33: Photochemical rearrangement of aryl azides.
Scheme 34: Rearrangement of quinoline N-oxides to quinolones.
Scheme 35: Photochemical rearrangement of cyclobutenones.
Scheme 36: Photoisomerisation en route to a vitamin-D derivative.
Scheme 37: Schematic of the Seeberger photooxygenation apparatus and sensitised photooxygenation of citronello...
Scheme 38: Sensitised photooxygenation of dihydroartemisinic acid.
Scheme 39: Photochemical preparation of CpRu(MeCN)3PF6.
Scheme 40: In situ photochemical generation and reaction of a [CpRu]+ catalyst.
Scheme 41: Intermolecular alkene–alkyne coupling with photogenerated catalyst.
Scheme 42: PET deoxygenation of nucleosides.
Scheme 43: Photochemical defluorination of DABFT.
Scheme 44: Aromatic azide reduction by visible-light-mediated photocatalysis.
Scheme 45: Examples of visible-light-mediated reactions.
Scheme 46: Visible-light-mediated formation of iminium ions.
Scheme 47: Examples of visible-light-mediated photocatalytic reactions.
Scheme 48: Anhydride formation from a visible-light-mediated process.
Scheme 49: Light-mediated conjugate addition of glycosyl bromide 141 to acrolein.
Scheme 50: Visible-light-mediated photocyclisation to [5]helicene.
Beilstein J. Org. Chem. 2012, 8, 1400–1405, doi:10.3762/bjoc.8.162
Graphical Abstract
Figure 1: Related compounds of eletriptan hydrobromide.
Scheme 1: Synthetic route of eletriptan hydrobromide. Reagents and conditions: (i) Acetic anhydride, TEA, DMF...
Scheme 2: Dimerization of 13. Reagents and conditions: (i) NaH, THF, 30–35 °C, 2 h; 11.6% yield after column ...
Scheme 3: Formation of the isomers 3 and 4. Reagents and conditions: (i) Aqueous hydrogen peroxide, methanol,...
Scheme 4: Synthesis of impurity 5. Reagents and conditions: (i) Acetic anhydride, TEA, DMF, 90–100 °C; (ii) p...
Scheme 5: Debromination of 9 to 6. Reagents and conditions: Palladium on carbon, ethanol, ca. 7 bar, 25–30 °C...
Scheme 6: Formation of 7. Reagents, conditions: (i) (a) K2CO3, methanol, reflux, 2 days; 40% yield after colu...
Scheme 7: Synthesis of the tetracyclic compound 7. Reagents and conditions: (i) aqueous hydrogen peroxide, wa...
Beilstein J. Org. Chem. 2011, 7, 1494–1498, doi:10.3762/bjoc.7.173
Graphical Abstract
Figure 1: Oxidation reactions with P450cam-RhFRed mutants.
Scheme 1: Whole cell biotransformation of diphenylmethane to 4-hydroxydiphenylmethane with P450cam(Y96A)-RhFR...
Beilstein J. Org. Chem. 2011, 7, 1347–1359, doi:10.3762/bjoc.7.159
Graphical Abstract
Scheme 1: Hydrogenation of ethyl pyruvate.
Scheme 2: Hydrogenation of dimethyl itaconate.
Scheme 3: a) Enantioselective hydrogenation of N-(1-phenylethylidene)aniline in IL–CO2; b) Enantioselective h...
Scheme 4: Selective hydroformylation with a silica supported Rh catalyst.
Scheme 5: Enantioselective hydroformylation of styrene.
Scheme 6: Enantioselective hydrovinylation of styrene.
Scheme 7: Enantioselective cyclopropanation of styrene catalyzed by supported Cu–BOX, Cu–PyOX and Rh–PyBOX ca...
Scheme 8: Continuous hydrogenation of acetophenone coupled with the kinetic resolution of the product.
Scheme 9: Kinetic resolution of phenylethanol using CALB immobilized in ILs and supported ILs.
Beilstein J. Org. Chem. 2011, 7, 442–495, doi:10.3762/bjoc.7.57
Graphical Abstract
Figure 1: Structures of atorvastatin and other commercial statins.
Figure 2: Structure of compactin.
Scheme 1: Synthesis of pentasubstituted pyrroles.
Scheme 2: [3 + 2] Cycloaddition to prepare 5-isopropylpyrroles.
Scheme 3: Regiospecific [3 + 2] cycloaddition to prepare the pyrrole scaffold.
Scheme 4: Formation of the pyrrole core of atorvastatin via [3 + 2] cycloaddition.
Scheme 5: Formation of pyrrole 33 via the Paal–Knorr reaction.
Scheme 6: Convergent synthesis towards atorvastatin.
Figure 3: Binding pocket of sunitinib in the TRK KIT.
Scheme 7: Synthesis of sunitinib.
Scheme 8: Alternative synthesis of sunitinib.
Scheme 9: Key steps in the syntheses of sumatriptan and zolmitriptan.
Scheme 10: Introduction of the N,N-dimethylaminoethyl side chain.
Scheme 11: Japp–Klingemann reaction in the synthesis of sumatriptan.
Scheme 12: Synthesis of the intermediate sulfonyl chlorides 62 and 63.
Scheme 13: Alternative introduction of the sulfonamide.
Scheme 14: Negishi-type coupling to benzylic sulfonamides.
Scheme 15: Heck reaction used to introduce the sulfonamide side chain of naratriptan.
Scheme 16: Synthesis of the oxazolinone appendage of zolmitriptan.
Scheme 17: Grandberg indole synthesis used in the preparation of rizatriptan.
Scheme 18: Improved synthesis of rizatriptan.
Scheme 19: Larock-type synthesis of rizatriptan.
Scheme 20: Synthesis of eletriptan.
Scheme 21: Heck coupling for the indole system in eletriptan.
Scheme 22: Attempted Fischer indole synthesis of elatriptan.
Scheme 23: Successful Fischer indole synthesis for eletriptan.
Scheme 24: Mechanistic rationale for the Bischler–Möhlau reaction.
Scheme 25: Bischler-type indole synthesis used in the fluvastatin sodium synthesis.
Scheme 26: Palladium-mediated synthesis of ondansetron.
Scheme 27: Fischer indole synthesis of ondansetron.
Scheme 28: Optimised Pictet–Spengler reaction towards tadalafil.
Figure 4: Structures of carvedilol 136 and propranolol 137.
Scheme 29: Synthesis of the carbazole core of carvedilol.
Scheme 30: Alternative syntheses of 4-hydroxy-9H-carbazole.
Scheme 31: Convergent synthesis of etodolac.
Scheme 32: Alternative synthesis of etodolac.
Figure 5: Structures of imidazole-containing drugs.
Scheme 33: Synthesis of functionalised imidazoles towards losartan.
Scheme 34: Direct synthesis of the chlorinated imidazole in losartan.
Scheme 35: Synthesis of trisubstituted imidazoles.
Scheme 36: Preparation of the imidazole ring in olmesartan.
Scheme 37: Synthesis of ondansetron.
Scheme 38: Alternative route to ondansetron and its analogues.
Scheme 39: Proton pump inhibitors and synthesis of esomeprazole.
Scheme 40: Synthesis of benzimidazole core pantoprazole.
Figure 6: Structure of rabeprazole 194.
Scheme 41: Synthesis of candesartan.
Scheme 42: Alternative access to the candesartan key intermediate 216.
Scheme 43: .Medicinal chemistry route to telmisartan.
Scheme 44: Improved synthesis of telmisartan.
Scheme 45: Synthesis of zolpidem.
Scheme 46: Copper-catalysed 3-component coupling towards zolpidem.
Figure 7: Structure of celecoxib.
Scheme 47: Preparation of celecoxib.
Scheme 48: Alternative synthesis of celecoxib.
Scheme 49: Regioselective access to celecoxib.
Scheme 50: Synthesis of pazopanib.
Scheme 51: Syntheses of anastrozole, rizatriptan and letrozole.
Scheme 52: Regioselective synthesis of anastrozole.
Scheme 53: Triazine-mediated triazole formation towards anastrozole.
Scheme 54: Alternative routes to 1,2,4-triazoles.
Scheme 55: Initial synthetic route to sitagliptin.
Figure 8: Binding of sitagliptin within DPP-IV.
Scheme 56: The process route to sitagliptin key intermediate 280.
Scheme 57: Synthesis of maraviroc.
Scheme 58: Synthesis of alprazolam.
Scheme 59: The use of N-nitrosoamidine derivatives in the preparation of fused benzodiazepines.
Figure 9: Structures of itraconazole, ravuconazole and voriconazole.
Scheme 60: Synthesis of itraconazole.
Scheme 61: Synthesis of rufinamide.
Scheme 62: Representative tetrazole formation in valsartan.
Figure 10: Structure of tetrazole containing olmesartan, candesartan and irbesartan.
Scheme 63: Early stage introduction of the tetrazole in losartan.
Scheme 64: Synthesis of cilostazol.
Figure 11: Structure of cefdinir.
Scheme 65: Semi-synthesis of cefdinir.
Scheme 66: Thiazole syntheses towards ritonavir.
Scheme 67: Synthesis towards pramipexole.
Scheme 68: Alternative route to pramipexole.
Scheme 69: Synthesis of famotidine.
Scheme 70: Efficient synthesis of the hyperuricemic febuxostat.
Scheme 71: Synthesis of ziprasidone.
Figure 12: Structure of mometasone.
Scheme 72: Industrial access to 2-furoic acid present in mometasone.
Scheme 73: Synthesis of ranitidine from furfuryl alcohol.
Scheme 74: Synthesis of nitrofurantoin.
Scheme 75: Synthesis of benzofuran.
Scheme 76: Synthesis of amiodarone.
Scheme 77: Synthesis of raloxifene.
Scheme 78: Alternative access to the benzo[b]thiophene core of raloxifene.
Scheme 79: Gewald reaction in the synthesis of olanzapine.
Scheme 80: Alternative synthesis of olanzapine.
Figure 13: Access to simple thiophene-containing drugs.
Scheme 81: Synthesis of clopidogrel.
Scheme 82: Pictet–Spengler reaction in the preparation of tetrahydrothieno[3,2-c]pyridine (422).
Scheme 83: Alternative synthesis of key intermediate 422.
Figure 14: Co-crystal structures of timolol (left) and carazolol (right) in the β-adrenergic receptor.
Scheme 84: Synthesis of timolol.
Scheme 85: Synthesis of tizanidine 440.
Scheme 86: Synthesis of leflunomide.
Scheme 87: Synthesis of sulfamethoxazole.
Scheme 88: Synthesis of risperidone.
Figure 15: Relative abundance of selected transformations.
Figure 16: The abundance of heterocycles within top 200 drugs (5-membered rings).